Alien Field Report 001 — Gene Therapy, Protein Degraders & CRISPR (Apr/May 2026)

Alien Field Report 001 — Gene Therapy, Protein Degraders & CRISPR (Apr/May 2026)
An alien reporter transmits Field Report 001: three landmark FDA approvals reshaping human biology — Otarmeni (gene therapy for deafness), Veppanu (first PROTAC degrader), and lonvo-z (first Phase 3 CRISPR win).
